PiepoliMFHoesAWAgewallS, et al.
2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J2016;
37: 2315–2381.
2.
KetolaELaatikainenTVartiainenE.Evaluating risk for cardiovascular diseases–vain or value? How do different cardiovascular risk scores act in real life. Eur J Public Health2010;
20: 107–112.
3.
BittencourtMSBlanksteinRBlahaMJ, et al.
Implications of coronary artery calcium testing on risk stratification for lipid-lowering therapy according to the 2016 European Society of Cardiology recommendations: The MESA study. Eur J Prev Cardiol2018;
25: 1887–1898.
4.
Fernández-FrieraLPeñalvoJLFernández-OrtizA, et al.
Prevalence, vascular distribution, and multiterritorial extent of subclinical atherosclerosis in a middle-aged cohort: The PESA (Progression of Early Subclinical Atherosclerosis) Study. Circulation2015;
131: 2104–2113.
5.
OkwuosaTMGreenlandPNingH, et al.
Yield of screening for coronary artery calcium in early middle-age adults based on the 10-year Framingham Risk Score: The CARDIA study. JACC Cardiovasc Imaging2012;
5: 923–930.
6.
LakoskiSGGreenlandPWongND, et al.
Coronary artery calcium scores and risk for cardiovascular events in women classified as “low risk” based on Framingham risk score: The multi-ethnic study of atherosclerosis (MESA). Arch Intern Med2007;
167: 2437–2442.
7.
ÖstgrenCJSöderbergSFestinK, et al.
SCORE estimated risk and prevalent subclinical atherosclerosis in coronary and carotid arteries - A population-based cohort analysis from the Swedish cardiopulmonary BioImage study. Eur J Prev Cardiol2020. Epub ahead of print; DOI: 10.1177/2047487320909300.
8.
BaberUMehranRSartoriS, et al.
Prevalence, impact, and predictive value of detecting subclinical coronary and carotid atherosclerosis in asymptomatic adults: The BioImage study. J Am Coll Cardiol2015;
65: 1065–1074.
9.
OrnishDScherwitzLWBillingsJH, et al.
Intensive lifestyle changes for reversal of coronary heart disease. JAMA1998;
280: 2001–2007.
10.
LeeSEChangHJSungJM, et al.
Effects of statins on coronary atherosclerotic plaques: The PARADIGM Study. JACC Cardiovasc Imaging2018;
11: 1475–1484.
11.
NewbyDE.Computed tomography or functional stress testing for the prediction of risk: Can I have my cake and eat it?Circulation2017;
136: 2006–2008.
12.
GepnerADYoungRDelaneyJA, et al.
Comparison of carotid plaque score and coronary artery calcium score for predicting cardiovascular disease events: The Multi-Ethnic Study of Atherosclerosis. J Am Heart Assoc2017;
6: e005179.
13.
FaggianoPDasseniNGaibazziN, et al.
Cardiac calcification as a marker of subclinical atherosclerosis and predictor of cardiovascular events: A review of the evidence. Eur J Prev Cardiol2019;
26: 1191–1204.
